BCC Excision Revisited

To readdress basal cell carcinoma (BCC) in the periocular region to prove histologically controlled surgical treatment efficacy and to identify high-risk characteristics.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Basal Cell Carcinoma Carcinoma Carcinoma, Basal Cell Eye Cancer Eye Diseases Eye Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Basal Cell Neoplasms, Glandular and Epithelial

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Vienna

Vienna, 1090, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient records were reviewed for the presence of BCC and surgical excision with frozen sections control of the wound margins in the periocular region,
conducted between 01.01.2009 and 31.12.2019.
Periocular was defined as the area involving the medial and lateral canthus as well as the upper and lower eyelids.

Exclusion criteria

BCCs outside of this region were excluded from this analysis,
as well as incomplete records.

Treatment and study plan

Surgery

Procedure

Surgical Excision

Primary outcomes

BCC Recurrence

Time frame: mean 3-5 years

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Long-term Results After Surgical Basal Cell Carcinoma Excision in the Eyelid Region: Revisited

Important dates

Study start: 2019
Primary completion: 2023
Study completion: 2023
First posted: May 10, 2023
Registry last updated: May 16, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed